This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: L-Carnitine Supplementation During Hepatitis C Virus Treatment with Sofosbuvir/Daclatasvir Plus Ribavirin: Effect on Anemia: A Pilot Study, The Medical Journal of Cairo University, June 2019, Egypts Presidential Specialized Council for Education and Scientific Research,
DOI: 10.21608/mjcu.2019.54882.
You can read the full text:
The following have contributed to this page
